Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients' point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.
The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism / C. Alfieri, A. Regalia, F. Zanoni, S. Vettoretti, M. Cozzolino, P. Messa. - In: BLOOD PURIFICATION. - ISSN 0253-5068. - (2018 Sep 17). [Epub ahead of print] [10.1159/000492918]
The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism
C. Alfieri
;M. CozzolinoPenultimo
;P. MessaUltimo
2018
Abstract
Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients' point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.File | Dimensione | Formato | |
---|---|---|---|
BP2018.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
78.31 kB
Formato
Adobe PDF
|
78.31 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.